Canada markets closed

Sonnet BioTherapeutics Holdings, Inc. (SONN)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.8604-0.0696 (-3.61%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.71M
Enterprise Value 2.88M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)27.49
Price/Book (mrq)2.22
Enterprise Value/Revenue 22.26
Enterprise Value/EBITDA -0.20

Trading Information

Stock Price History

Beta (5Y Monthly) 1.12
52-Week Change 3-65.09%
S&P500 52-Week Change 322.38%
52 Week High 326.4000
52 Week Low 31.0800
50-Day Moving Average 31.9018
200-Day Moving Average 32.7866

Share Statistics

Avg Vol (3 month) 3103.57k
Avg Vol (10 day) 313.34k
Shares Outstanding 53.07M
Implied Shares Outstanding 63.07M
Float 82.71M
% Held by Insiders 19.22%
% Held by Institutions 13.53%
Shares Short (Apr 15, 2024) 4424.16k
Short Ratio (Apr 15, 2024) 47.85
Short % of Float (Apr 15, 2024) 414.22%
Short % of Shares Outstanding (Apr 15, 2024) 413.82%
Shares Short (prior month Mar 15, 2024) 4557.46k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 02, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:22
Last Split Date 3Sept 01, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-6,866.05%

Management Effectiveness

Return on Assets (ttm)-175.81%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)129.18k
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)-50.00%
Gross Profit (ttm)N/A
EBITDA -14.45M
Net Income Avi to Common (ttm)-14.46M
Diluted EPS (ttm)-0.8300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.02M
Total Cash Per Share (mrq)0.98
Total Debt (mrq)186.69k
Total Debt/Equity (mrq)7.26%
Current Ratio (mrq)1.74
Book Value Per Share (mrq)0.84

Cash Flow Statement

Operating Cash Flow (ttm)-18.52M
Levered Free Cash Flow (ttm)-13.56M